Skip to content
Open access

Diagnostic performance of the dengue Ag NS1 rapid test in Peruvian adults with suspected dengue virus infection

Oct 2026 · Scientific Reports · Vol 16 · 0 citations · 21 references

Abstract

Dengue, transmitted by Aedes aegypti, remains a critical public health challenge in tropical regions, with Peru experiencing upsetting increases in cases. Rapid immunochromatographic tests for NS1 antigen detection are vital in resource-limited settings, but their performance must be validated against gold-standard methods like RT-PCR. To determine the sensitivity, specificity, and diagnostic accuracy of the OnSite® Dengue NS1 rapid test compared to RT-PCR in a high-prevalence setting. A cross-sectional study analyzed 140 serum samples from suspected dengue cases (2021–2022) stored at -70 °C. RT-PCR served as the reference standard. Sensitivity, specificity, predictive values, AUC-ROC, and Cohen’s kappa were calculated using Stata v18. We found a mean age of 32.2 years, and 54% of the participants were woman. We assessed a dengue prevalence of 51.4% by RT-PCR. The rapid test detected NS1 with 88.89% sensitivity (95% CI: 79.28–95.08) and 100% specificity (95% CI: 94.72–100). The AUC was 94.44% (90.79–98.10), indicating high diagnostic accuracy. Concordance with RT-PCR was excellent (κ = 88.6). The test showed 94.29% overall accuracy, with 100% positive predictive value and 89.47% negative predictive value. However, 11.1% (8/72) of PCR-confirmed cases were false negatives. No false positives occurred. Most samples were collected 3–5 days post-symptom onset, aligning with peak NS1 detectability. The CTK Biotech OnSite® Dengue NS1 rapid test demonstrated high specificity and moderate sensitivity, making it a reliable tool for dengue screening in endemic areas. Its performance supports its use in resource-limited settings, though false negatives underscore the need for complementary testing in clinically suspicious cases.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.